295 related articles for article (PubMed ID: 29663350)
1. The role of AMPA receptors and their antagonists in status epilepticus.
Leo A; Giovannini G; Russo E; Meletti S
Epilepsia; 2018 Jun; 59(6):1098-1108. PubMed ID: 29663350
[TBL] [Abstract][Full Text] [Related]
2. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E
Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657
[TBL] [Abstract][Full Text] [Related]
3. Early polytherapy for benzodiazepine-refractory status epilepticus.
Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
[TBL] [Abstract][Full Text] [Related]
4. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
[TBL] [Abstract][Full Text] [Related]
5. AMPA receptor desensitization as a determinant of vulnerability to focally evoked status epilepticus.
Fornai F; Busceti CL; Kondratyev A; Gale K
Eur J Neurosci; 2005 Jan; 21(2):455-63. PubMed ID: 15673444
[TBL] [Abstract][Full Text] [Related]
6. AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.
Di Bonaventura C; Labate A; Maschio M; Meletti S; Russo E
Expert Opin Pharmacother; 2017 Nov; 18(16):1751-1764. PubMed ID: 29023170
[TBL] [Abstract][Full Text] [Related]
7. Perampanel but Not Amantadine Prevents Behavioral Alterations and Epileptogenesis in Pilocarpine Rat Model of Status Epilepticus.
Mohammad H; Sekar S; Wei Z; Moien-Afshari F; Taghibiglou C
Mol Neurobiol; 2019 Apr; 56(4):2508-2523. PubMed ID: 30039334
[TBL] [Abstract][Full Text] [Related]
8. Perampanel in the treatment of status epilepticus: A systematic review of the literature.
Brigo F; Lattanzi S; Rohracher A; Russo E; Meletti S; Grillo E; Trinka E
Epilepsy Behav; 2018 Sep; 86():179-186. PubMed ID: 30076046
[TBL] [Abstract][Full Text] [Related]
9. Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466.
Fritsch B; Stott JJ; Joelle Donofrio J; Rogawski MA
Epilepsia; 2010 Jan; 51(1):108-17. PubMed ID: 19682025
[TBL] [Abstract][Full Text] [Related]
10. The Roles of Glutamate Receptors and Their Antagonists in Status Epilepticus, Refractory Status Epilepticus, and Super-Refractory Status Epilepticus.
Huang TH; Lai MC; Chen YS; Huang CW
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979664
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
Langer M; Brandt C; Zellinger C; Löscher W
Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
[TBL] [Abstract][Full Text] [Related]
12. Perampanel Treatment for Refractory Status Epilepticus in a Neurological Intensive Care Unit.
Ho CJ; Lin CH; Lu YT; Shih FY; Hsu CW; Tsai WC; Tsai MH
Neurocrit Care; 2019 Aug; 31(1):24-29. PubMed ID: 30891695
[TBL] [Abstract][Full Text] [Related]
13. Novel drugs and early polypharmacotherapy in status epilepticus.
Amengual-Gual M; Sánchez Fernández I; Wainwright MS
Seizure; 2019 May; 68():79-88. PubMed ID: 30473267
[TBL] [Abstract][Full Text] [Related]
14. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models.
Löscher W
Epilepsy Behav; 2015 Aug; 49():20-5. PubMed ID: 25819944
[TBL] [Abstract][Full Text] [Related]
15. Fifty years of research on status epilepticus: Seizures use hippocampal memory circuits to generate status epilepticus and disrupt brain development.
Wasterlain C
Epilepsy Behav; 2023 Apr; 141():109142. PubMed ID: 36907081
[TBL] [Abstract][Full Text] [Related]
16. AMPA receptors in epilepsy and as targets for antiepileptic drugs.
Rogawski MA; Donevan SD
Adv Neurol; 1999; 79():947-63. PubMed ID: 10514878
[TBL] [Abstract][Full Text] [Related]
17. Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.
Strzelczyk A; Knake S; Kälviäinen R; Santamarina E; Toledo M; Willig S; Rohracher A; Trinka E; Rosenow F
Acta Neurol Scand; 2019 Apr; 139(4):369-376. PubMed ID: 30613951
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of status epilepticus: α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor hypothesis.
Joshi S; Kapur J
Epilepsia; 2018 Oct; 59 Suppl 2(Suppl 2):78-81. PubMed ID: 30159880
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of convulsive status epilepticus.
Sánchez Fernández I; Goodkin HP; Scott RC
Seizure; 2019 May; 68():16-21. PubMed ID: 30170734
[TBL] [Abstract][Full Text] [Related]
20. Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy.
Citraro R; Aiello R; Franco V; De Sarro G; Russo E
Expert Opin Ther Targets; 2014 Mar; 18(3):319-34. PubMed ID: 24387310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
